Wednesday, March 29, 2023
Clinical Advances in
Read Overview
Supported by an independent educational grant from Lilly
Steering Committee Member Chair
Professor of Neurology Mayo Clinic College of Medicine Director of Mayo Clinic Alzheimer's Disease Research Center and Mayo Clinic Study of Aging Rochester, Minnesota United States
Professor of Clinical Family Medicine Keck USC School of Medicine Los Angeles, California Professor Emerita of Psychiatry and Behavioral Sciences University of Washington School of Medicine Seattle, Washington United States
Medical Director Toronto Memory Program Toronto, Ontario, Canada
Professor of Family Medicine Boston University School of Medicine Department of Family Medicine Boston, Massachusetts United States
Scientific Director Alzheimer Center Amsterdam Amsterdam University Medical Center, Amsterdam, The Netherlands
Professor of Neurochemistry Department of Psychiatry and Neurochemistry The Sahlgrenska Academy at the University of Gothenburg Mölndal, Sweden
Steering Committee Chair
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Biogen; Eisai, Inc.; Genentech, Inc.; Nestlé; Merck & Co., Inc.; Roche
Has disclosed no relevant financial relationships.
Served as an advisor or consultant for: Biogen; Genentech, Inc.
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alnylam; Biogen; Cassava Sciences; Eli Lilly; INmune Bio; ProMIS Neurosciences, Inc.; Roche (no personal fees received; all fees paid to institution only)
Received grants for clinical research from: Alector; Anavex; AgeneBio; Biogen; Cassava; Eli Lilly; Green Valley; Janssen; Novo Nordisk; Roche; Vielight (all fees paid to institution only)
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: AbbVie; Acadia; Allergan; Eisai; Supernus; Takeda
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Roche; Biogen MA Inc. (all funding paid to her institution)
Served as a speaker or a member of a speakers bureau for: Biogen MA Inc.; Danone; Eisai
Received grants for clinical research from: AVID; Biogen MA Inc.; Combinostics; Fujifilm; Life-MI; Novartis NL; Philips; Roche BV
Other: Serve as an independent contractor(including contracted research) for the following ineligible company: Biogen MA Inc. (all funding to institute)
Has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Abbvie; Alector; Annexon; Artery Therapeutics; AZTherapies; Cognition Therapeutics, Inc.; Denali; Eisai; Nervgen; Passage Bio; Pinteon Therapeutics; Red Abbey Labs; Roche; Samumed; Siemens Healthineers; Triplet Therapeutics; Wave Have given lectures in symposia sponsored by: AlzeCure; Biogen; Cellectricon; Fujirebio; Roche
Owns stock, stock options, or bonds from: co-founder and stockholder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program at the University of Gothenburg
